Class information for: |
Basic class information |
Class id | #P | Avg. number of references |
Database coverage of references |
---|---|---|---|
22274 | 388 | 44.5 | 94% |
Hierarchy of classes |
The table includes all classes above and classes immediately below the current class. |
Cluster id | Level | Cluster label | #P |
---|---|---|---|
0 | 4 | BIOCHEMISTRY & MOLECULAR BIOLOGY//CELL BIOLOGY//ONCOLOGY | 4064930 |
204 | 3 | PROTEASOME//UBIQUITIN//UNFOLDED PROTEIN RESPONSE | 52492 |
1195 | 2 | JNK//ERK5//MAP KINASE | 9252 |
22274 | 1 | ERK5//MEK5//EXTRACELLULAR SIGNAL REGULATED KINASE 5 | 388 |
Terms with highest relevance score |
rank | Term | termType | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|---|
1 | ERK5 | authKW | 4061806 | 21% | 65% | 80 |
2 | MEK5 | authKW | 1052218 | 5% | 70% | 19 |
3 | EXTRACELLULAR SIGNAL REGULATED KINASE 5 | authKW | 811831 | 4% | 74% | 14 |
4 | MEKK2 | authKW | 634829 | 3% | 73% | 11 |
5 | EXTRACELLULAR SIGNAL REGULATED KINASE 5 ERK5 | authKW | 579504 | 2% | 82% | 9 |
6 | BMK1 | authKW | 524651 | 3% | 67% | 10 |
7 | BIG MITOGEN ACTIVATED PROTEIN KINASE 1 BMK1 | authKW | 236096 | 1% | 100% | 3 |
8 | BIX02189 | authKW | 236096 | 1% | 100% | 3 |
9 | DISTAL CEREBROSPINAL FLUID CONTACTING NEURONS | authKW | 236096 | 1% | 100% | 3 |
10 | THE DISTAL CEREBROSPINAL FLUID CONTACTING NEURONS | authKW | 236096 | 1% | 100% | 3 |
Web of Science journal categories |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | Cell Biology | 1658 | 34% | 0% | 132 |
2 | Biochemistry & Molecular Biology | 1005 | 43% | 0% | 168 |
3 | Oncology | 330 | 17% | 0% | 65 |
4 | Biophysics | 95 | 7% | 0% | 26 |
5 | Peripheral Vascular Diseases | 51 | 4% | 0% | 16 |
6 | Neurosciences | 40 | 9% | 0% | 33 |
7 | Hematology | 39 | 4% | 0% | 15 |
8 | Genetics & Heredity | 26 | 5% | 0% | 19 |
9 | Immunology | 17 | 5% | 0% | 20 |
10 | Physiology | 17 | 3% | 0% | 13 |
Address terms |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | IST TOSCANO TUMORI CORE | 157397 | 1% | 100% | 2 |
2 | JIANGSU PROVINCE ANAESTHESIOL | 157397 | 1% | 100% | 2 |
3 | ABSL3 | 78699 | 0% | 100% | 1 |
4 | AFFLIDATED HOSP | 78699 | 0% | 100% | 1 |
5 | BIOMED SCI IMMUNOL PROGRAMS | 78699 | 0% | 100% | 1 |
6 | BLSMD | 78699 | 0% | 100% | 1 |
7 | CANCPROGRAM MOL CELLULAR BIOL | 78699 | 0% | 100% | 1 |
8 | DEV MOL BIOLHLTH SCI | 78699 | 0% | 100% | 1 |
9 | IFR GFAS 140CNRS UMR 6061CELL CYCLE GRP | 78699 | 0% | 100% | 1 |
10 | INTEGRATED BIOLBUNKYO KU | 78699 | 0% | 100% | 1 |
Journals |
Rank | Term | Chi square | Shr. of publ. in class containing term |
Class's shr. of term's tot. occurrences |
#P with term in class |
---|---|---|---|---|---|
1 | CELLULAR SIGNALLING | 4610 | 4% | 0% | 16 |
2 | MOLECULAR AND CELLULAR BIOLOGY | 1123 | 5% | 0% | 18 |
3 | JOURNAL OF BIOLOGICAL CHEMISTRY | 1006 | 12% | 0% | 45 |
4 | EMBO REPORTS | 575 | 1% | 0% | 4 |
5 | CIRCULATION RESEARCH | 487 | 2% | 0% | 8 |
6 | ONCOGENE | 420 | 3% | 0% | 10 |
7 | ONCOTARGET | 398 | 2% | 0% | 8 |
8 | CURRENT SIGNAL TRANSDUCTION THERAPY | 361 | 0% | 0% | 1 |
9 | ONCOLOGY LETTERS | 225 | 1% | 0% | 4 |
10 | BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS | 207 | 4% | 0% | 14 |
Author Key Words |
Core articles |
The table includes core articles in the class. The following variables is taken into account for the relevance score of an article in a cluster c: (1) Number of references referring to publications in the class. (2) Share of total number of active references referring to publications in the class. (3) Age of the article. New articles get higher score than old articles. (4) Citation rate, normalized to year. |
Rank | Reference | # ref. in cl. |
Shr. of ref. in cl. |
Citations |
---|---|---|---|---|
1 | NITHIANANDARAJAH-JONES, GN , WILM, B , GOLDRING, CEP , MULLER, J , CROSS, MJ , (2012) ERK5: STRUCTURE, REGULATION AND FUNCTION.CELLULAR SIGNALLING. VOL. 24. ISSUE 11. P. 2187 -2196 | 72 | 58% | 48 |
2 | LOCHHEAD, PA , GILLEY, R , COOK, SJ , (2012) ERK5 AND ITS ROLE IN TUMOUR DEVELOPMENT.BIOCHEMICAL SOCIETY TRANSACTIONS. VOL. 40. ISSUE . P. 251 -256 | 45 | 74% | 35 |
3 | WANG, X , TOURNIER, C , (2006) REGULATION OF CELLULAR FUNCTIONS BY THE ERK5 SIGNALLING PATHWAY.CELLULAR SIGNALLING. VOL. 18. ISSUE 6. P. 753 -760 | 50 | 69% | 162 |
4 | WILHELMSEN, K , XU, FY , FARRAR, K , TRAN, A , KHAKPOUR, S , SUNDAR, S , PRAKASH, A , WANG, JH , GRAY, NS , HELLMAN, J , (2015) EXTRACELLULAR SIGNAL-REGULATED KINASE 5 PROMOTES ACUTE CELLULAR AND SYSTEMIC INFLAMMATION.SCIENCE SIGNALING. VOL. 8. ISSUE 391. P. - | 62 | 51% | 1 |
5 | DREW, BA , BUROW, ME , BECKMAN, BS , (2012) MEK5/ERK5 PATHWAY: THE FIRST FIFTEEN YEARS.BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER. VOL. 1825. ISSUE 1. P. 37-48 | 56 | 51% | 44 |
6 | SIMOES, AES , RODRIGUES, CMP , BORRALHO, PM , (2016) THE MEK5/ERK5 SIGNALLING PATHWAY IN CANCER: A PROMISING NOVEL THERAPEUTIC TARGET.DRUG DISCOVERY TODAY. VOL. 21. ISSUE 10. P. 1654 -1663 | 54 | 56% | 0 |
7 | ROBERTS, OL , HOLMES, K , MULLER, J , CROSS, DAE , CROSS, MJ , (2009) ERK5 AND THE REGULATION OF ENDOTHELIAL CELL FUNCTION.BIOCHEMICAL SOCIETY TRANSACTIONS. VOL. 37. ISSUE . P. 1254-1259 | 46 | 70% | 37 |
8 | YANG, QK , LEE, JD , (2011) TARGETING THE BMK1 MAP KINASE PATHWAY IN CANCER THERAPY.CLINICAL CANCER RESEARCH. VOL. 17. ISSUE 11. P. 3527-3532 | 43 | 69% | 10 |
9 | INESTA-VAQUERA, FA , CAMPBELL, DG , TOURNIER, C , GOMEZ, N , LIZCANO, JM , CUENDA, A , (2010) ALTERNATIVE ERK5 REGULATION BY PHOSPHORYLATION DURING THE CELL CYCLE.CELLULAR SIGNALLING. VOL. 22. ISSUE 12. P. 1829-1837 | 34 | 79% | 15 |
10 | NITHIANANDARAJAH-JONES, GN , WILM, B , GOLDRING, CEP , MULLER, J , CROSS, MJ , (2014) THE ROLE OF ERK5 IN ENDOTHELIAL CELL FUNCTION.BIOCHEMICAL SOCIETY TRANSACTIONS. VOL. 42. ISSUE . P. 1584 -1589 | 40 | 63% | 1 |
Classes with closest relation at Level 1 |
Rank | Class id | link |
---|---|---|
1 | 36872 | FAM83D//FAM83B//ANAT DEV REGENERAT BIOL |
2 | 16802 | MEF2C//MEF2//MEF2D |
3 | 9419 | DUAL SPECIFICITY PHOSPHATASE//MKP 1//MAP KINASE PHOSPHATASE |
4 | 33806 | MODULAR PHARMACOLOGY//RAS RAF ERK1 2//RAS RAF ERK1 2 SIGNALING PATHWAY |
5 | 5457 | JNK//MKK4//C JUN N TERMINAL KINASE |
6 | 9970 | MAP KINASE KINASE//MAP KINASE//MAP KINASE ACTIVATOR |
7 | 19822 | PAR 4//ATYPICAL PROTEIN KINASE C//PROTEIN KINASE C IOTA |
8 | 5307 | MK2//P38 INHIBITORS//P38 ALPHA |
9 | 29236 | TPL2//TPL 2//COT TPL2 |
10 | 24101 | MIXED LINEAGE KINASE//RPM 1//DLK |